BioSpace News Archive

Deals

GE to Spin Off GE Healthcare as a Standalone Company

GE Healthcare will be spun off from General Electric (GE) within the next 12 to 18 months. It will likely be based in Chicago, where its global headquarters are located.

June 26, 2018
·
3 min read
·
Mark Terry
Bio NC

Precision BioSciences Closed on a $110 Million Series B Financing

Precision BioSciences closed on an oversubscribed Series B financing worth $110 million. The funds will be used to continue developing its ARCUS genome editing platform.

June 26, 2018
·
2 min read
·
Mark Terry
Business

Kraig Biocraft Laboratories Works with Local Cooperative to Expand Mulberry Production in Quang Nam, Vietnam

Plans to add nearly 2,500 acres of mulberry to support commercialization scale up of the Company’s recombinant spider silk technology

June 26, 2018
·
2 min read
Drug Development

Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression

NV-5138 is a specific and direct activator of mTORC1, a cellular pathway required for the efficacy of many rapid acting antidepressants

June 26, 2018
·
6 min read
Biotech Beach

Pancreatic Cancer Action Network Funds Innovative Scientists through Research Grants Program

2018 Awards Contribute to PanCAN’s $48 Million Research Investment

June 26, 2018
·
2 min read
Business

Elligo Health Research and HealthiVibe Partner to Deliver Patient Insights

Elligo Health Research has partnered with HealthiVibe. The goal of the partnership is to bring the patient to the center of the clinical trial experience.

June 26, 2018
·
3 min read
Biotech Beach

Puma Biotechnology Announces Results of CHMP Reexamination of MAA for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

Positive trend vote recommending the approval of the Marketing Authorisation Application (MAA) for neratinib for the extended adjuvant treatment of early stage HER2-positive hormone receptor positive breast cancer.

June 26, 2018
·
5 min read
Business

ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform

ProBioGen AG and Nouscom AG, today jointly announced signing a license agreement.

June 26, 2018
·
2 min read
Business

Cardurion Pharmaceuticals Announces Formation of Scientific and Clinical Advisory Board

Cardurion Pharmaceuticals is pleased to share the members of its Scientific and Clinical Advisory Boards.

June 26, 2018
·
4 min read
BioMidwest

Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock

Aerpio will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018

June 26, 2018
·
3 min read